Global Oncology Nutrition Market – Industry Trends and Forecast to 2030

Запрос на TOC Запрос на TOC Обратиться к аналитику Обратиться к аналитику Бесплатный пример отчета Бесплатный пример отчета Узнать перед покупкой Узнать перед покупкой Купить сейчас Купить сейчас

Global Oncology Nutrition Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Oct 2023
  • Global
  • 350 Pages
  • Количество таблиц: 60
  • Количество рисунков: 220

Обходите тарифные трудности с помощью гибкого консалтинга в области цепочки поставок

Анализ экосистемы цепочки поставок теперь является частью отчетов DBMR

Global Oncology Nutrition Market

Размер рынка в млрд долларов США

CAGR :  % Diagram

Chart Image USD 1,974.75 Million USD 3,630.83 Million 2022 2030
Diagram Прогнозируемый период
2023 –2030
Diagram Размер рынка (базовый год)
USD 1,974.75 Million
Diagram Размер рынка (прогнозируемый год)
USD 3,630.83 Million
Diagram CAGR
%
Diagram Основные игроки рынка
  • FMC Corporation
  • Danone
  • Abbott
  • Aceto
  • B. Braun Melsungen AG

Global Oncology Nutrition Market, By Cancer Type (Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Pancreatic Cancer, Liver Cancer, Blood Cancer, Breast Cancer, Lung Cancer, Others), Nutrition (Enteral Nutrition, Parenteral Nutrition), Formula (Standard Formula, Elemental Formula, Specialized Formula), Route of Administration (Oral, Parenteral), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.

Oncology Nutrition Market

Oncology Nutrition Market Analysis and Size

The rise in the prevalence of cancer is the major driver resulting in the expansion of market’s growth. Another significant factor influencing the growth rate of oncology nutrition market is the rising healthcare expenditure. Additionally, rise in the number of clinical trials, rapid product origination and increase in the focus on enteral nutrition will cushion the growth rate of oncology nutrition market. Moreover, the rise in the research and development activities and launch of new products for the nutrition of oncology patients will provide beneficial opportunities for the oncology nutrition market in the forecast period of 2023-2030. Also, developments of elemental formulas and emerging new markets will escalate the growth rate global oncology nutrition market in future.

Data Bridge Market Research analyses that the global oncology nutrition market, which was USD 1974.75 million in 2022, is expected to reach USD 3630.83 million by 2030, and is expected to undergo a CAGR of 7.91% during the forecast period 2023-2030. This indicates that the Head and Neck Cancer segment dominates the cancer type segment of the global oncology nutrition market owing to the advancements in technology. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Oncology Nutrition Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

 Cancer Type (Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Pancreatic Cancer, Liver Cancer, Blood Cancer, Breast Cancer, Lung Cancer, Others), Nutrition (Enteral Nutrition, Parenteral Nutrition), Formula (Standard Formula, Elemental Formula, Specialized Formula), Route of Administration (Oral, Parenteral), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

FMC Corporation (U.S.), Danone  (India), Abbott (U.S.), Aceto (U.S.), B. Braun Melsungen AG (Germany),Baxter (U.S.), Fresenius Kabi AG (Germany),Global Health Products, Inc. (U.S.),  Hormel Foods Corporation (U.S.), Mead Johnson & Company, LLC (U.S.), Meiji Holdings Co., Ltd (Japan), Nestlé S.A.( Switzerland), BioSig Technologies, Inc. (U.S.), Auris Health, Inc. (U.S.)

Market Opportunities

  • Rising Technology Advancement in Cancer Treatment
  • Growing awareness of the importance of nutrition in cancer care
  • Rising healthcare expenditure

Market Definition

Cancer is characterised by the unregulated proliferation of aberrant cells. Tumor cells or malignant cells are the names given to these cells. Oncology is the branch of medicine that deals with the prevention, treatment and diagnosis of cancer. Oncology nutrition refers to the nutrition and diet that a cancer patient consumes during and after therapy. Nutrition is a crucial therapy during cancer treatment and plays a key influence in numerous aspects of cancer development. Appropriate diet can help cancer patients maintain a healthy weight and body composition, resulting in improved healing and a higher quality of life.

Global Oncology Nutrition Market Dynamics

Drivers

  • Increasing Prevalence of Cancer

The rising incidence of cancer worldwide is a major driver for the global oncology nutrition market. Cancer patients often experience malnutrition and weight loss due to the disease itself or its treatments, creating a demand for specialized nutrition products.

  • Growing Awareness of the Importance of Nutrition in Cancer Care

There is a growing recognition among healthcare professionals about the significant impact of nutrition on cancer treatment outcomes. This has led to increased emphasis on personalized nutrition plans for cancer patients, driving the demand for oncology nutrition products.

  • Focus on Supportive Care in Cancer Management

Supportive care, including nutritional support, is an integral part of comprehensive cancer management. Oncology nutrition plays a crucial role in managing treatment-related side effects, improving quality of life, and enhancing treatment outcomes.

Opportunities

  • Advancements in Cancer Treatments

 Advancements in cancer treatments, such as chemotherapy, radiation therapy, and targeted therapies, have improved survival rates. However, these treatments can cause side effects like appetite loss, taste changes, and difficulty swallowing, creating a need for specialized nutrition support.

  • Rising Healthcare Expenditure

Increasing healthcare expenditure, particularly in emerging economies, has led to improved access to cancer treatments and supportive care services. This has contributed to the growth of the global oncology nutrition market.

Restraints/Challenges

  • High Cost of Specialized Oncology Nutrition Products

Oncology-specific nutrition products can be expensive compared to regular nutritional supplements. The high cost may limit affordability and accessibility, particularly in lower-income regions, leading to restricted market growth.

  • Limited Reimbursement Coverage

In some healthcare systems, reimbursement coverage for oncology nutrition products may be limited or non-existent. This can pose challenges for patients and healthcare providers in accessing and utilizing these specialized products, affecting market growth

This global oncology nutrition market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global oncology nutrition market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • On July 2021, Nestlé Health Science, a leading player in the oncology nutrition market, announced the expansion of its portfolio with the launch of two new products: Resource® ThickenUp Clear Oncology and Resource ThickenUp Clear Oncology Ready-To-Drink. These products are designed to provide hydration and nutrition support for cancer patients with swallowing difficulties
  • On June, 2021, Abbott, a global healthcare company, introduced ProSure Oncology in India. ProSure Oncology is a specialized nutritional supplement designed to support the nutritional needs of cancer patients undergoing treatment. It is formulated with high-quality protein, omega-3 fatty acids, and a blend of vitamins and minerals

Global Oncology Nutrition Market Scope

The global oncology nutrition market is segmented on the basis of cancer type, nutrition, and formula, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Cancer Type

  • Head and Neck Cancer
  •  Stomach and Gastrointestinal Cancers
  •  Esophageal Cancer
  •  Pancreatic Cancer
  •  Liver Cancer
  •  Blood Cancer
  •  Breast Cancer
  •  Lung Cancer
  •  Others

Nutrition

  • Enteral Nutrition
  • Parenteral Nutrition

Formula

  • Standard Formula
  •  Elemental Formula
  •  Specialized Formula

Route of Administration

  • Oral
  • Parenteral

 End-Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Global Oncology Nutrition Market Regional Analysis/Insights

The global oncology nutrition market is analysed and market size insights and trends are provided by country, cancer type, nutrition, formula, route of administration, end-users and distribution channel as referenced above.

The countries covered in the global oncology nutrition market  report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the global oncology nutrition market because of the strong base of healthcare facilities, strong presence of major players in the market, rising demand of the  Oncology Nutrition products and rising number of research activities in this region.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global oncology nutrition market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global oncology nutrition market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global oncology nutrition market. The data is available for historic period 2015-2020.

Competitive Landscape and Global Oncology Nutrition Market Share Analysis

The global oncology nutrition market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global oncology nutrition market.

Some of the major players operating in the global oncology nutrition market are:

  • FMC Corporation (U.S.)
  •  Danone (India)
  •  Abbott (U.S.)
  •  Aceto (U.S.)
  •  B. Braun Melsungen AG (Germany)
  • Baxter (U.S.)
  •  Fresenius Kabi AG (Germany)
  • Global Health Products, Inc. (U.S.)
  •   Hormel Foods Corporation (U.S.)
  •  Mead Johnson & Company, LLC (U.S.)
  •  Meiji Holdings Co., Ltd (Japan)
  •  Nestlé S.A. (Switzerland)
  •  BioSig Technologies, Inc. (U.S.)
  •  Auris Health, Inc. (U.S.)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Интерактивная панель анализа данных
  • Панель анализа компании для возможностей с высоким потенциалом роста
  • Доступ аналитика-исследователя для настройки и запросов
  • Анализ конкурентов с помощью интерактивной панели
  • Последние новости, обновления и анализ тенденций
  • Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Запросить демонстрацию

Методология исследования

Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.

Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.

Доступна настройка

Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.

Часто задаваемые вопросы

Рынок сегментирован на основе , By Cancer Type (Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Pancreatic Cancer, Liver Cancer, Blood Cancer, Breast Cancer, Lung Cancer, Others), Nutrition (Enteral Nutrition, Parenteral Nutrition), Formula (Standard Formula, Elemental Formula, Specialized Formula), Route of Administration (Oral, Parenteral), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030. .
Размер Global Oncology Nutrition Market в 2022 году оценивался в 1974.75 USD Million долларов США.
Ожидается, что Global Oncology Nutrition Market будет расти со среднегодовым темпом роста (CAGR) 7.91% в течение прогнозируемого периода 2023–2030.
Основные участники рынка включают FMC Corporation , Danone, Abbott , Aceto , B. Braun Melsungen AG ,Baxter , Fresenius Kabi AG ,Global Health ProductsInc. ,Hormel Foods Corporation , Mead Johnson &amp, CompanyLLC , Meiji Holdings Co.Ltd , Nestl&eacute, S.A., BioSig TechnologiesInc. , Auris HealthInc. .
Отчет по рынку охватывает данные из U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Testimonial